Shares of Rentokil Initial PLC (NYSE:RTO – Get Free Report) have earned a consensus rating of “Hold” from the thirteen brokerages that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $31.90.
Several research firms have recently issued reports on RTO. Morgan Stanley downgraded Rentokil Initial from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 29th. Zacks Research upgraded shares of Rentokil Initial from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 22nd. The Goldman Sachs Group reiterated a “buy” rating on shares of Rentokil Initial in a research report on Monday, October 5th. Wall Street Zen lowered shares of Rentokil Initial from a “buy” rating to a “hold” rating in a report on Monday, July 20th. Finally, Stifel Nicolaus upgraded shares of Rentokil Initial from a “hold” rating to a “buy” rating in a research report on Monday, October 5th.
Check Out Our Latest Analysis on RTO
Rentokil Initial Price Performance
Rentokil Initial stock opened at $22.59 on Tuesday. The stock has a 50-day moving average price of $21.92 and a two-hundred day moving average price of $28.56. Rentokil Initial has a 12 month low of $19.50 and a 12 month high of $34.67. The company has a current ratio of 1.06, a quick ratio of 0.98 and a debt-to-equity ratio of 0.65.
Rentokil Initial Cuts Dividend
The firm also recently declared a dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Friday, August 14th were issued a dividend of $0.2240 per share. This represents a dividend yield of 188.0%. This is a drop from Rentokil Initial’s previous dividend of $0.4120. The ex-dividend date was Friday, August 14th.
Institutional Trading of Rentokil Initial
Several institutional investors have recently modified their holdings of the business. Janus Henderson Group PLC raised its position in Rentokil Initial by 3.0% during the 1st quarter. Janus Henderson Group PLC now owns 16,591,965 shares of the company’s stock worth $522,329,000 after purchasing an additional 490,885 shares during the last quarter. Bank of America Corp DE grew its position in shares of Rentokil Initial by 60.7% in the 1st quarter. Bank of America Corp DE now owns 6,650,998 shares of the company’s stock valued at $209,373,000 after buying an additional 2,511,135 shares during the last quarter. Assetmark Inc. grew its position in shares of Rentokil Initial by 29.0% in the 1st quarter. Assetmark Inc. now owns 837,035 shares of the company’s stock valued at $26,350,000 after buying an additional 188,190 shares during the last quarter. Rockefeller Capital Management L.P. grew its position in shares of Rentokil Initial by 5.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 816,863 shares of the company’s stock valued at $24,065,000 after buying an additional 40,024 shares during the last quarter. Finally, Liberty One Investment Management LLC increased its stake in shares of Rentokil Initial by 7.7% in the first quarter. Liberty One Investment Management LLC now owns 625,994 shares of the company’s stock valued at $19,706,000 after buying an additional 44,823 shares during the period. Institutional investors own 9.91% of the company’s stock.
Rentokil Initial Company Profile
Rentokil Initial plc (NYSE:RTO) is a business services company headquartered in the United Kingdom. It provides pest control, hygiene, and workplace services to commercial, public-sector, and residential customers. Its offerings are designed to help organizations manage pests, maintain sanitary environments, and support health, safety, and workplace standards.
The company’s pest control services address insects, rodents, and other pests, while its hygiene operations provide washroom services, sanitary products, air care, floor-care solutions, and related workplace services.
Further Reading
- Five stocks we like better than Rentokil Initial
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
